DrugPatentWatch Database Preview
TRIZIVIR Drug Profile
» See Plans and Pricing
Which patents cover Trizivir, and when can generic versions of Trizivir launch?
Trizivir is a drug marketed by Viiv Hlthcare and is included in one NDA.
The generic ingredient in TRIZIVIR is abacavir sulfate; lamivudine; zidovudine. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the abacavir sulfate; lamivudine; zidovudine profile page.
Summary for TRIZIVIR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Clinical Trials: | 20 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TRIZIVIR |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TRIZIVIR |
| What excipients (inactive ingredients) are in TRIZIVIR? | TRIZIVIR excipients list |
| DailyMed Link: | TRIZIVIR at DailyMed |
Paragraph IV (Patent) Challenges for TRIZIVIR
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| TRIZIVIR | TABLET;ORAL | abacavir sulfate; lamivudine; zidovudine | 021205 | 2011-03-22 |
US Patents and Regulatory Information for TRIZIVIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viiv Hlthcare | TRIZIVIR | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 021205-001 | Nov 14, 2000 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRIZIVIR
International Patents for TRIZIVIR
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2078234 | Start Trial |
| African Regional IP Organization (ARIPO) | 300 | Start Trial |
| Germany | 3650492 | Start Trial |
| Slovakia | 125793 | Start Trial |
| Germany | 196185 | Start Trial |
| Taiwan | 254939 | Start Trial |
| Monaco | 1766 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for TRIZIVIR
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0817637 | 300195 | Netherlands | Start Trial | 300195, 20160328, EXPIRES: 20191216 |
| 0434450 | C990028 | Netherlands | Start Trial | PRODUCT NAME: ABACAVIR, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN/OF VAN EEN FARMACEUTISCH AANVAARDBAAR ESTER, IN HET BIJZONDER ABACAVIR SULFAAT; REGISTRATION NO/DATE: EU/1/99/112/001-002 19990708 |
| 0434450 | SPC/GB99/032 | United Kingdom | Start Trial | PRODUCT NAME: ABACAVIR, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR DERIVATIVE INCLUDING ABACAVIR SULPHATE; REGISTERED: CH CH 55048 001 19990628; CH CH 55049 002 19990628; UK EU/1/99/112/001 19990708; UK EU/1/99/112/002 19990708 |
| 0434450 | 33/1999 | Austria | Start Trial | PRODUCT NAME: ''ABACAVIR'', GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES ODER DERIVATS, EINSCHLIESSLICH ABACAVIR-SULFAT.; NAT. REGISTRATION NO/DATE: EU/1/99/112/001 EU/1/99/112/002 19990708; FIRST REGISTRATION: LI 55048 001, 55049 002 19990628 |
| 0817637 | 23/2005 | Austria | Start Trial | PRODUCT NAME: KOMBINATION, UMFASSEND ABACAVIR BZW. EIN PHYSIOLOGISCH AKZEPTABLES SALZ, ESTER, SALZ DES ESTERS ODER SOLVAT DAVON UND LAMIVUDIN BZW. EIN PHYSIOLOGISCH AKZEPTABLES SALZ, ESTER, SALZ DES; REGISTRATION NO/DATE: EU/1/04/298/001, EU/1/04/298/002 20041217 |
| 0817637 | CA 2005 00028 | Denmark | Start Trial | |
| 0434450 | 1999C0033 | Belgium | Start Trial | PRODUCT NAME: ABACAVIR SULFATE; NATL. REGISTRATION NO/DATE: EU/1/99/112/001 19990708; FIRST REGISTRATION: CH 55048 19990628 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
